Columbus Venture led a €42m Series B round in Arthex Biotech.

Columbus Venture, a venture capital firm, led a €42m Series B round in Arthex Biotech, a biotechnology engineer, with the participation of the European Innovation Council fund, Hadean Ventures, Sound Bioventures, Invivo Capital, AdBio Partners, and CDTI. “EIT Health has helped Arthex develop and scale as a start-up company,” Beatriz Llamusí, Arthex Biotech CEO, CSO and Co-Founder.